ros1 treatment options: lorlatinib and repotrectinib - 2022 program: targeted therapies forum
Published 1 year ago • 253 plays • Length 3:26Download video MP4
Download video MP3
Similar videos
-
7:07
ros1 treatment options: crizotinib and entrectinib - 2022 program: targeted therapies forum
-
3:55
disease progression on lorlatinib or osimertinib - 2022 program: targeted therapies forum
-
5:42
ros1 nsclc: diagnosing and treatment - 2022 program: targeted therapies forum
-
4:10
side effects of ros1-tkis - 2022 program: targeted therapies forum
-
7:53
ret nsclc treatment options - 2022 program: targeted therapies forum
-
2:49
treatments for ret nsclc: selpercatinib vs. pralsetinib - 2022 program: targeted therapies forum
-
1:39
grace targeted therapies lung cancer 2021 - treatment after crizotinib in ros1 lung cancer
-
2:43
ros1 nsclc: is it possible to develop a second mutation? - 2022 program: targeted therapies forum
-
3:56
how to identify ret nsclc - 2022 program: targeted therapies forum
-
2:01
grace targeted therapies lung cancer 2021 - data learned from ensartinib for ros1 in clinical trial?
-
10:50
treatment options & study data for patients with ros1 nsclc- targeted therapies in lung cancer 2023
-
2:02
grace targeted therapies lung cancer 2021 - second line ros1 medication off-label
-
1:54
grace targeted therapies lung cancer 2021 - ros1 pairing partner and influence on ros1 tkis?
-
31:43
new ideas and new treatment options for acquired resistance for alk/ros1
-
3:06
grace targeted therapies lung cancer 2021 - tki plus chemotherapy as a firstline treatment in ros1?
-
4:02
ros1 nsclc: chemotherapy and immunotherapy -
-
1:43
developing nodularities on alectinib: is it pneumonitis? - 2022 program: targeted therapies forum